Status:
COMPLETED
A New Supplement for the Immune Response to HPV Infection
Lead Sponsor:
University of Messina
Conditions:
HPV Infection
Eligibility:
FEMALE
20-50 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate whether a supplement in which ellagic acid plus annona muricata are combined, may modulate the immune response to high risk HPV infection. Sixty women will be ...
Eligibility Criteria
Inclusion
- women with high risk HPV infection
- histological diagnosis of L-SIL
Exclusion
- women with no high risk HPV infection
- women without histological diagnosis of L-SIL
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02263378
Start Date
September 1 2014
End Date
March 1 2016
Last Update
May 24 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.